Takeda launches Enzyme Replacement Therapy portfolio for lysosomal storage disorders in India
Takeda brings to market Idursulfase for hunter syndrome, Velaglucerase Alpha for gaucher disease and Agalsidase Alfa for fabry…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.